Compare
Corcept Therapeutics vs Johnson & Johnson (CORT vs JNJ)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Corcept Therapeutics (CORT) returned -5.1% and Johnson & Johnson (JNJ) +48.5%; so far this year the figures are +109.1% and +33.5%.
Johnson & Johnson is the larger company by market value, about 83.5 times the size of Corcept Therapeutics.
On trailing earnings, CORT trades at 57.3 times and JNJ at 41.9 times.
Revenue grew +30.0% at CORT and +7.8% at JNJ over the last year.
CORT pays no dividend. JNJ yields 1.91%.
Data as of the latest close. Not investment advice.
Relative performance
| CORT | JNJ | |
|---|---|---|
| Price | $72.77 | $276.22 |
| 1-day | +1.59% | +1.43% |
| YTD | +109.11% | +33.47% |
| 1 year | -5.06% | +48.51% |
| 3 years | +159.06% | +85.77% |
| Market cap | $8.0B | $665.0B |
| P/E | 57.3 | 41.9 |
| P/S | 8.26 | 6.69 |
| P/B | 9.55 | 8.16 |
| Revenue growth | +30.00% | +7.80% |
| EPS growth | +46.00% | -36.40% |
| Gross margin % | 98.5 | 67.6 |
| Net margin % | 16.8 | 16.2 |
| ROE % | 19.5 | 19.7 |
| Debt / equity | 0.00 | 0.55 |
| FCF yield % | 2.4 | 3.1 |
| Dividend yield % | — | 1.91 |
| Beta | 1.96 | -0.09 |
| RSI (14) | 22.0 | 59.4 |
| Technical rating |